AbbVie has now produced a policy report that draws on the findings of our consultation and calls for change to help involve patients across the NHS in treatment and care decisions. Central to this, we see three pillars of opportunity:
- Enabling empowered conversations through support for both healthcare professionals and patients;
- Achieving buy-in through increased levels of support, visibility and understanding of SDM amongst senior leadership at Board level.
- Utilising the opportunity to re-engineer pathways and processes during NHS Restart to embed SDM into treatment pathways.
To achieve this, AbbVie will continue to bring together key decision makers, patient groups and other stakeholders to support the spread and adoption of best practice in SDM.
If you would like more information about this work or the projects
showcased at the event, please email AbbvieSharedDecision@mhpc.com